VT vs. XBI

Last updated Jun 16, 2026

VT (Vanguard Total World Stock ETF) and XBI (SPDR S&P Biotech ETF) are both exchange-traded funds - VT is a Global Equities fund tracking the FTSE Global All Cap Index, while XBI is a Health & Biotech Equities fund tracking the S&P Biotechnology Select Industry Index. Both are passively managed. Over the past 10 years, VT returned 13.03%/yr vs 9.98%/yr for XBI. A 0.59 correlation means they provide meaningful diversification when combined. VT charges 0.06%/yr vs 0.35%/yr for XBI.

Performance

VT vs. XBI - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Vanguard Total World Stock ETF (VT) and SPDR S&P Biotech ETF (XBI). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, VT achieves a 12.78% return, which is significantly higher than XBI's 11.87% return. Over the past 10 years, VT has outperformed XBI with an annualized return of 13.03%, while XBI has yielded a comparatively lower 9.98% annualized return.

VT

• 1D: 1.55%
• 1M: 3.39%
• YTD: 12.78%
• 6M: 13.56%
• 1Y: 29.41%
• 3Y*: 19.92%
• 5Y*: 11.15%
• 10Y*: 13.03%

XBI

• 1D: 1.95%
• 1M: 4.37%
• YTD: 11.87%
• 6M: 11.41%
• 1Y: 63.76%
• 3Y*: 16.08%
• 5Y*: 0.52%
• 10Y*: 9.98%

*Multi-year figures are annualized to reflect compound growth (CAGR)

VT vs. XBI - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
VT Vanguard Total World Stock ETF	12.78%	22.43%	16.49%	22.02%	-18.00%	18.27%	16.59%	26.81%	-9.76%	24.50%
XBI SPDR S&P Biotech ETF	11.87%	35.89%	1.01%	7.60%	-25.87%	-20.45%	48.33%	32.56%	-15.28%	43.77%

Correlation

The correlation between VT and XBI is 0.54, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.54
Correlation (3Y) Calculated over the trailing 3-year period	0.58
Correlation (5Y) Calculated over the trailing 5-year period	0.60
Correlation (10Y) Calculated over the trailing 10-year period	0.59
Correlation (All Time) Calculated using the full available price history since Jun 26, 2008	0.59

The correlation between VT and XBI has been stable across timeframes, ranging from 0.54 to 0.60 - a consistent structural relationship.

VT vs. XBI - Sectors Allocation Comparison

Sectors	VT	XBI
Technology	27.8%	-
Financial Services	15.9%	0.3%
Industrials	12.0%	-
Consumer Cyclical	9.5%	-
Communication Services	8.3%	-
Healthcare	8.1%	99.7%
Consumer Defensive	4.8%	-
Energy	4.3%	-
Basic Materials	4.2%	0.2%
Utilities	2.7%	-
Real Estate	2.4%	-

Return for Risk

VT vs. XBI — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

VT

VT Risk / Return Rank: 75
VT Sharpe Ratio Rank: 78
VT Sortino Ratio Rank: 76
VT Omega Ratio Rank: 77
VT Calmar Ratio Rank: 67
VT Martin Ratio Rank: 77

XBI

XBI Risk / Return Rank: 86
XBI Sharpe Ratio Rank: 85
XBI Sortino Ratio Rank: 83
XBI Omega Ratio Rank: 74
XBI Calmar Ratio Rank: 94
XBI Martin Ratio Rank: 91

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

VT vs. XBI - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Vanguard Total World Stock ETF (VT) and SPDR S&P Biotech ETF (XBI). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	VT	XBI	Difference
Sharpe ratio: Return per unit of total volatility	2.21	2.45	-0.25
Sortino ratio: Return per unit of downside risk	3.02	3.29	-0.27
Omega ratio: Gain probability vs. loss probability	1.40	1.39	+0.01
Calmar ratio: Return relative to maximum drawdown	3.05	6.59	-3.54
Martin ratio: Return relative to average drawdown	13.29	19.47	-6.18

VT vs. XBI - Sharpe Ratio Comparison

The current VT Sharpe Ratio is 2.21, which is comparable to the XBI Sharpe Ratio of 2.45. The chart below compares the historical Sharpe Ratios of VT and XBI, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

VT vs. XBI - Drawdown Comparison

The maximum VT drawdown since its inception was -50.27%, smaller than the maximum XBI drawdown of -63.89%. Use the drawdown chart below to compare losses from any high point for VT and XBI.

Drawdown Indicators

	VT	XBI	Difference
Max Drawdown Largest peak-to-trough decline	-50.27%	-63.89%	+13.62%
Max Drawdown (1Y) Largest decline over 1 year	-9.67%	-9.72%	+0.05%
Max Drawdown (3Y) Largest decline over 3 years	-16.51%	-32.99%	+16.48%
Max Drawdown (5Y) Largest decline over 5 years	-26.38%	-54.71%	+28.33%
Max Drawdown (10Y) Largest decline over 10 years	-34.24%	-63.89%	+29.65%
Current Drawdown Current decline from peak	-0.40%	-21.16%	+20.76%
Average Drawdown Average peak-to-trough decline	-7.01%	-20.93%	+13.92%
Ulcer Index Depth and duration of drawdowns from previous peaks	2.22%	3.29%	-1.07%

Volatility

VT vs. XBI - Volatility Comparison

The current volatility for Vanguard Total World Stock ETF (VT) is 5.46%, while SPDR S&P Biotech ETF (XBI) has a volatility of 10.55%. This indicates that VT experiences smaller price fluctuations and is considered to be less risky than XBI based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	VT	XBI	Difference
Volatility (1M) Calculated over the trailing 1-month period	5.46%	10.55%	-5.09%
Volatility (6M) Calculated over the trailing 6-month period	11.11%	20.83%	-9.72%
Volatility (1Y) Calculated over the trailing 1-year period	13.41%	26.18%	-12.77%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	16.17%	32.22%	-16.05%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	17.28%	32.03%	-14.75%

VT vs. XBI - Expense Ratio Comparison

VT has a 0.06% expense ratio, which is lower than XBI's 0.35% expense ratio.

Dividends

VT vs. XBI - Dividend Comparison

VT's dividend yield for the trailing twelve months is around 1.58%, more than XBI's 0.32% yield.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
VT Vanguard Total World Stock ETF	1.58%	1.82%	1.95%	2.08%	2.20%	1.82%	1.66%	2.32%	2.53%	2.11%	2.39%	2.45%
XBI SPDR S&P Biotech ETF	0.32%	0.37%	0.15%	0.02%	0.00%	0.04%	0.20%	0.00%	0.28%	0.24%	0.26%	0.61%

Frequently Asked Questions

Can I hold both VT and XBI in my portfolio?

VT and XBI have a correlation of 0.54, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, VT or XBI?

XBI has higher volatility (10.55%) compared to VT (5.46%). In terms of maximum drawdown, VT dropped -50.27% vs XBI's -63.89%.

Which ETF is better, VT or XBI?

On 10-year performance, VT leads with 13.03% vs 9.98% for XBI. On fees, VT is cheaper at 0.06% per year. On volatility, VT has been the lower-risk option at 5.46%. The better choice depends on whether you care most about return, fees, risk, or income.

Which ETF has performed better, VT or XBI?

Over the 10-year period, VT has performed better with a 13.03% return vs 9.98%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

Which ETF is cheaper, VT or XBI?

VT is cheaper with a 0.06% expense ratio, compared with 0.35% for XBI.

Which ETF pays a higher dividend yield, VT or XBI?

VT has the higher dividend yield at 1.58%, compared with 0.32% for XBI.

What is the main difference between VT and XBI?

VT is categorized as Global Equities, while XBI is Health & Biotech Equities. VT tracks FTSE Global All Cap Index, while XBI tracks S&P Biotechnology Select Industry Index. They also come from different issuers: Vanguard and State Street. Their fees differ too: 0.06% for VT and 0.35% for XBI.

Which has better risk-adjusted returns?

XBI currently has the higher Sharpe Ratio (2.45 vs 2.21), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.